Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission

Clinical trial NCT00209300 · COMPLETED

Trial details

NCT number: NCT00209300
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2005-05-01
Primary completion: 2007-05-01
Enrollment: 362

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.